Failed takeover bid takes toll on Adcock

Adcock Ingram Holdings, South Africa’s largest supplier of hospital products, posted a nine-month loss amid changes being made to the structure of the business after a failed takeover bid.

The loss per share, excluding one-time items, was R1.80 in the nine months through June, compared with a profit of R2.72 a year earlier, the Johannesburg-based company said on Thursday in a statement. Sales were little changed at R3.6-billion.

“We believe that to reorganise this business is appropriate because that way we can focus on growing our top line to compensate for the cost increases that we’re experiencing,” chief executive Kevin Wakeford said by phone on Thursday. “I’m not expecting any quick fixes,” Wakeford said. “We are going to give the changes a little bit of time to gain traction in the market.”

Adcock was the subject of a 10-month battle for control after profit margins came under pressure from rising production costs and a weaker rand in 2012. CFR Pharmaceuticals SA, Chile’s biggest drug maker, called off a R12.8-billion cash and stock offer to buy Adcock after Johannesburg-based Bidvest Group built a blocking stake. Bidvest chief executive Brian Joffe became Adcock’s new chairman with Wakeford becoming chief executive.

The shares were down 0.1% at R51.94 rand as of 10.53am in Johannesburg, after falling 27% this year. Bidvest paid R70 per share to build a 34.5% stake in January.


Adcock’s reorganisation includes the separation of the business into five divisions to create greater accountability, according to Wakeford.– Bloomberg

Subscribe to the M&G

These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever.

The Mail & Guardian is a proud news publisher with roots stretching back 35 years, and we’ve survived right from day one thanks to the support of readers who value fiercely independent journalism that is beholden to no-one. To help us continue for another 35 future years with the same proud values, please consider taking out a subscription.

Related stories

SME airs dirty laundry on ‘fronting’

A small business is accusing a Bidvest-affiliated company of turning its partnership one-sided

KFC falls fowl in Britain with chicken run

Hundreds of KFC outlets remained shut in the the UK due to a supply crisis after the company changed delivery partners

Frenzy of misinformation at the Nasrec expo centre

Fake news about each factions — and their strategies to take down the competitions — abound at #ANC54

SA football agents to be prosecuted for price fixing

A statement released by the Competition Commission, SAFIA and its members "agreed to charge soccer players and coaches a standard 10% commission fee".

Rand bubbles to the top as volatility subsides

The South African local currency is expected to continue strengthening as low volatility and high returns attract investors.

PIC wants local ownership to boost economy

The Public Investment Corporation, South Africa's biggest stock investor, says local ownership is key for growing the economy and empowering people.
Advertising

Subscribers only

Free State branches gun for Ace

Parts of the provincial ANC will target their former premier, Magashule, and the Free State PEC in a rolling mass action campaign

SAA bailout raises more questions

As the government continues to grapple with the troubles facing the airline, it would do well to keep on eye on the impending Denel implosion

More top stories

Hawks swoop down with more arrests in R1.4-billion corruption blitz

The spate of arrests for corruption continues apace in Gauteng and the Eastern Cape.

Catholic NGO boss accused of racism and abuse in Sudan

The aid worker allegedly called his security guard a ‘slave’

Agrizzi too ill to be treated at Bara?

The alleged crook’s “health emergency” — if that is what it is — shows up the flaws, either in our health system or in our leadership as a whole

SANDF hid R200m expenditure on ‘Covid’ drug it can’t use

Military health officials are puzzled by the defence department importing a drug that has not been approved for treating coronavirus symptoms from Cuba
Advertising

press releases

Loading latest Press Releases…

The best local and international journalism

handpicked and in your inbox every weekday